BR0011290A - Gene derivado de lawsonia e polipeptìdeos, peptìdeos e proteìnas de omph relacionados e seus usos - Google Patents

Gene derivado de lawsonia e polipeptìdeos, peptìdeos e proteìnas de omph relacionados e seus usos

Info

Publication number
BR0011290A
BR0011290A BR0011290-9A BR0011290A BR0011290A BR 0011290 A BR0011290 A BR 0011290A BR 0011290 A BR0011290 A BR 0011290A BR 0011290 A BR0011290 A BR 0011290A
Authority
BR
Brazil
Prior art keywords
lawsonia
omph
lawsonia intracellularis
peptides
proteins
Prior art date
Application number
BR0011290-9A
Other languages
English (en)
Inventor
Detelef Hasse
Michael Panaccio
Meri Sinistaj
Original Assignee
Agriculture Victoria Serv Pty
Australian Pork Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agriculture Victoria Serv Pty, Australian Pork Ltd filed Critical Agriculture Victoria Serv Pty
Publication of BR0011290A publication Critical patent/BR0011290A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

"GENE DERIVADO DE LAWSONIA E POLIPEPTìDEOS, PEPTìDEOS E PROTEìNAS DE OmpH RELACIONADOS E SEUS USOS". A presente invenção refere-se geralmente a composições terapêuticas para o tratamento e/ou a profilaxia de condições de doença intestinal em animais e aves causadas ou exacerbadas por Lawsonia intracellularis ou por microorganismos similares ou relacionados de outra maneira. Em particular, a presente invenção fornece um novo gene derivado de Lawsonia intracellularis que codifica um peptídeo, um polipeptídeo ou uma proteína de OmpH imunogênica que é particularmente útil como um antígeno na preparação de vacina para conferir imunidade humoral contra Lawsonia intracellularis e patógenos relacionados em hospedeiros animais. A presente invenção está também direcionada a processos para o tratamento e/ou a profilaxia de tais condições de doença intestinal e a agentes de diagnósticos e a procedimentos para a detecção de Lawsonia intracellularis ou microorganismos similares ou relacionados de outra maneira.
BR0011290-9A 1999-05-13 2000-05-11 Gene derivado de lawsonia e polipeptìdeos, peptìdeos e proteìnas de omph relacionados e seus usos BR0011290A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13398699P 1999-05-13 1999-05-13
PCT/AU2000/000438 WO2000069905A1 (en) 1999-05-13 2000-05-11 LAWSONIA DERIVED GENE AND RELATED OmpH POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES

Publications (1)

Publication Number Publication Date
BR0011290A true BR0011290A (pt) 2002-05-21

Family

ID=22461241

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0011290-9A BR0011290A (pt) 1999-05-13 2000-05-11 Gene derivado de lawsonia e polipeptìdeos, peptìdeos e proteìnas de omph relacionados e seus usos

Country Status (10)

Country Link
US (1) US20060018920A1 (pt)
EP (1) EP1183268A4 (pt)
JP (1) JP2003521881A (pt)
AU (2) AU767390B2 (pt)
BR (1) BR0011290A (pt)
CA (1) CA2372102A1 (pt)
MX (1) MXPA01011570A (pt)
NZ (1) NZ515330A (pt)
PE (1) PE20010237A1 (pt)
WO (1) WO2000069905A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6605696B1 (en) 1999-10-22 2003-08-12 Pfizer, Inc. Lawsonia intracellularis proteins, and related methods and materials
JP2004529854A (ja) * 2000-09-29 2004-09-30 アリゾナ・ボード・オブ・リージエンツ・オン・ビハーフ・オブ・ザ・ユニバーシテイー・オブ・アリゾナ 増殖性回腸炎のための改善されたワクチン及びその作製と使用の方法
ATE330013T1 (de) * 2000-12-20 2006-07-15 Intervet Int Bv Lawsonia intracellularis impfstoff
FR2844514B1 (fr) * 2002-09-16 2007-10-19 Neovacs Produit immunogene stable comprenant des heterocomplexes antigeniques, compositions les contenant et procede de preparation
KR20060112674A (ko) * 2003-12-09 2006-11-01 인터벳 인터내셔널 비.브이. 로소니아 인트라셀룰라리스 26 ｋｄ 서브유닛 백신
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US8398994B2 (en) 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
US20100129397A1 (en) 2006-12-11 2010-05-27 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5885823A (en) * 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
CN1145697C (zh) * 1995-11-30 2004-04-14 维多利亚农业服务控股公司 治疗和诊断组合物

Also Published As

Publication number Publication date
NZ515330A (en) 2003-04-29
MXPA01011570A (es) 2003-08-20
WO2000069905A1 (en) 2000-11-23
CA2372102A1 (en) 2000-11-23
PE20010237A1 (es) 2001-02-28
US20060018920A1 (en) 2006-01-26
AU2004200487A1 (en) 2004-03-04
AU4386000A (en) 2000-12-05
JP2003521881A (ja) 2003-07-22
EP1183268A4 (en) 2003-01-02
EP1183268A1 (en) 2002-03-06
AU767390B2 (en) 2003-11-06

Similar Documents

Publication Publication Date Title
KR101997756B1 (ko) 패혈증 예방 또는 치료용 조성물
AU2009286973B2 (en) Clostridial neurotoxins with altered persistency
CN105142653B (zh) 增强对肠病原体免疫应答的组合物和方法
JP7072921B2 (ja) Ａ群レンサ球菌ワクチン
EA005579B1 (ru) Пептиды, полученные из казеина, и их применение в терапии
CN107266582A (zh) 牙龈卟啉单胞菌感染的预防、治疗和诊断
RU2757426C2 (ru) Иммунногенный слитый белок
CA3145228A1 (en) African swine fever vaccine
KR102573154B1 (ko) 변성 펩티드
BR0011290A (pt) Gene derivado de lawsonia e polipeptìdeos, peptìdeos e proteìnas de omph relacionados e seus usos
BR0011292A (pt) Gene derivado de lawsonia e proteìnas, peptìdeos e polipeptìdeos sodc relacionados e seus usos
CN107261127A (zh) 免疫活性组合物
BR0011294A (pt) Gene derivado lawsonia e polipeptìdeos, peptìdeos e proteìnas flge relacionados e seus usos
ES2366176T3 (es) Citocinas aviares novedosas y secuencias genéticas que codifican para las mismas.
CN116437933A (zh) 病毒感染的治疗和预防
PT680765E (pt) Vacina para estirpe não tipável de haemophilus influenzae.
CN102488898B (zh) 龋齿疫苗及制备方法
BR9916549A (pt) Composição farmacêutica, vacina, proteìna, e, método para a prevenção ou tratamento de leishmaniose em um humano ou animal
Jungherr et al. Serologic relationships of mumps and Newcastle disease
BR0114835A (pt) Composições terapêuticas para tratamento de infecção por lawsonia spp
KR102369146B1 (ko) 코로나 백신 제형
ES2253784T3 (es) Nuevo polipeptido extraido de hemophilus paragallinarum y su procedimiento de produccion.
BR112022020438A2 (pt) Composições compreendendo três proteínas de fusão ospa para uso médico
KR20040008130A (ko) 면역 증강제
CN102772792B (zh) 一种预防龋齿的疫苗及其制备方法

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7O, 8O E 9O ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2008 DE 30/06/2009.